| Year |
Citation |
Score |
| 2023 |
Sebastian NT, Stokes WA, Behera M, Jiang R, Gutman DA, Huang Z, Burns A, Sukhatme V, Lowe MC, Ramalingam SS, Sukhatme VP, Moghanaki D. The Association of Improved Overall Survival with NSAIDs in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Clinical Lung Cancer. PMID 36804711 DOI: 10.1016/j.cllc.2022.12.013 |
0.346 |
|
| 2023 |
Seong CS, Huang C, Boese AC, Hou Y, Koo J, Mouw JK, Rupji M, Joseph G, Johnston HR, Claussen H, Switchenko JM, Behera M, Churchman M, Kolesar JM, Arnold SM, et al. Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis. Biorxiv : the Preprint Server For Biology. PMID 36747658 DOI: 10.1101/2023.01.26.525772 |
0.303 |
|
| 2021 |
Park D, Anisuzzaman ASM, Magis AT, Chen G, Xie M, Zhang G, Behera M, Sica GL, Ramalingam SS, Owonikoko TK, Deng X. Discovery of Small Molecule Bak Activator for Lung Cancer Therapy. Theranostics. 11: 8500-8516. PMID 34373755 DOI: 10.7150/thno.60349 |
0.325 |
|
| 2021 |
Akce M, Zakka K, Penley M, Jiang R, Khalil L, Alese OB, Shaib WL, Wu C, Behera M, El-Rayes BF. Impact of high-risk features for stage II adenocarcinoma of the appendix. Cancer Treatment and Research Communications. 27: 100329. PMID 33609973 DOI: 10.1200/Jco.2020.38.4_Suppl.795 |
0.301 |
|
| 2020 |
Rice SJ, Hyland V, Behera M, Ramalingam SS, Bunn P, Belani CP. Guidance on the clinical management of E-cigarette or Vaping Associated Lung Injury (EVALI)? Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32866653 DOI: 10.1016/J.Jtho.2020.08.012 |
0.309 |
|
| 2020 |
Shaib WL, Zakka KM, Jiang R, Yan M, Alese OB, Akce M, Wu C, Behera M, El-Rayes BF. Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer. Cancer. PMID 32697360 DOI: 10.1002/Cncr.33049 |
0.394 |
|
| 2020 |
Dingemans AC, Soo RA, Jazieh AR, Rice SJ, Kim YT, Teo LL, Warren GW, Xiao SY, Smit EF, Aerts JG, Yoon SH, Veronesi G, De Cobelli F, Ramalingam SS, Garassino MC, ... ... Behera M, et al. Treatment guidance for lung cancer patients during the COVID-19 pandemic. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32422364 DOI: 10.1016/J.Jtho.2020.05.001 |
0.417 |
|
| 2020 |
Press RH, Shafer SL, Jiang R, Buchwald ZS, Abugideiri M, Tian S, Morgan TM, Behera M, Sengupta S, Voloschin AD, Olson JJ, Hasan S, Blumenthal DT, Curran WJ, Eaton BR, et al. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification. Cancer. PMID 32342992 DOI: 10.1002/Cncr.32797 |
0.36 |
|
| 2020 |
Alese OB, Jiang R, Shaib W, Wu C, Akce M, Gaines T, Ni L, Behera M, El-Rayes BF. Young Adults With Pancreatic Cancer: National Trends in Treatment and Outcomes. Pancreas. PMID 32132513 DOI: 10.1097/Mpa.0000000000001502 |
0.35 |
|
| 2020 |
Allen PB, Ayers A, Behera M, Evens AM, Flowers C. A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma. Leukemia & Lymphoma. 1-10. PMID 32102579 DOI: 10.1080/10428194.2020.1731497 |
0.342 |
|
| 2020 |
Tian S, Switchenko JM, Buchwald ZS, Patel PR, Shelton JW, Kahn SE, Pillai RN, Steuer CE, Owonikoko TK, Behera M, Curran WJ, Higgins KA. Lung Stereotactic Body Radiotherapy and Concurrent Immunotherapy: A Multi-Center Safety and Toxicity Analysis. International Journal of Radiation Oncology, Biology, Physics. PMID 31982496 DOI: 10.1016/J.Ijrobp.2019.12.030 |
0.369 |
|
| 2020 |
Behera M, Steuer CE, Liu Y, Fernandez F, Fu C, Higgins KA, Gillespie TW, Pakkala S, Pillai RN, Force S, Belani CP, Khuri FR, Curran WJ, Ramalingam SS. Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis. The Oncologist. PMID 31943520 DOI: 10.1634/Theoncologist.2019-0661 |
0.461 |
|
| 2020 |
Moghanaki D, Jiang R, Gutman D, Burns A, Sukhatme V, Stokes W, Ramalingam SS, Sukhatme V, Behera M. Utilization patterns of immune checkpoint inhibitors (ICI) for non-small cell lung cancer (NSCLC) within the veterans health administration (VHA). Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E21630 |
0.406 |
|
| 2020 |
Qian D, Behera M, Steuer CE, Pakkala S, Carlisle JW, Owonikoko TK, Fischer-Valuck BW, Kesarwala AH, Bradley J, Curran WJ, Ramalingam SS, Higgins KA. KRAS G12C mutation associated outcomes among patients with locally advanced non-small cell lung cancer. Journal of Clinical Oncology. 38: e21079-e21079. DOI: 10.1200/Jco.2020.38.15_Suppl.E21079 |
0.471 |
|
| 2020 |
Joseph N, Hofmeister CC, Dhodapkar MV, Boise L, Lonial S, Behera M, Kaufman JL, Nooka AK. Efficacy of daratumumab + SOC versus SOC in myeloma induction regimens, by risk-stratification: Meta-analysis of phase III randomized control trials. Journal of Clinical Oncology. 38: e20512-e20512. DOI: 10.1200/Jco.2020.38.15_Suppl.E20512 |
0.304 |
|
| 2020 |
Zakka KM, Williamson S, Jiang R, Alese OB, Shaib WL, Wu C, Behera M, El-Rayes BF, Akce M. Impact of tumor side on clinical outcomes in stage II and III colon cancer with known microsatellite instability status. Journal of Clinical Oncology. 38: 4068-4068. DOI: 10.1200/Jco.2020.38.15_Suppl.4068 |
0.363 |
|
| 2019 |
Chen G, Park D, Magis AT, Behera M, Ramalingam SS, Owonikoko TK, Sica GL, Ye K, Zhang C, Chen Z, Curran WJ, Deng X. Mcl-1 interacts with Akt to promote lung cancer progression. Cancer Research. PMID 31662324 DOI: 10.1158/0008-5472.Can-19-0950 |
0.386 |
|
| 2019 |
Akce M, Jiang R, Zakka K, Wu C, Alese OB, Shaib WL, Behera M, El-Rayes BF. Clinical Outcomes of Small Bowel Adenocarcinoma. Clinical Colorectal Cancer. PMID 31606297 DOI: 10.1016/J.Clcc.2019.08.002 |
0.408 |
|
| 2019 |
Alese OB, Jiang R, Zakka KM, Wu C, Shaib W, Akce M, Behera M, El-Rayes BF. Analysis of racial disparities in the treatment and outcomes of colorectal cancer in young adults. Cancer Epidemiology. 63: 101618. PMID 31600666 DOI: 10.1016/J.Canep.2019.101618 |
0.333 |
|
| 2019 |
Tian S, Jiang R, Madden NA, Ferris MJ, Buchwald ZS, Xu KM, Cardona K, Maithel SK, McDonald MW, Lin JY, Curran WJ, El-Rayes BF, Behera M, Patel PR. Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy. Cancer. PMID 31532544 DOI: 10.1002/Cncr.32516 |
0.397 |
|
| 2019 |
Tian S, Zhang X, Jiang R, Pillai RN, Owonikoko TK, Steuer CE, Saba NF, Pakkala S, Patel PR, Belani CP, Khuri FR, Curran WJ, Ramalingam SS, Behera M, Higgins KA. Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database. Clinical Lung Cancer. PMID 31296433 DOI: 10.1016/J.Cllc.2019.06.014 |
0.5 |
|
| 2019 |
Goldstein JS, Switchenko JM, Behera M, Flowers CR, Koff JL. Insurance status impacts overall survival in Burkitt lymphoma. Leukemia & Lymphoma. 1-10. PMID 31274033 DOI: 10.1080/10428194.2019.1623884 |
0.41 |
|
| 2019 |
Arciero CA, Guo Y, Jiang R, Behera M, O'Regan R, Peng L, Li X. ER/HER2 Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER-/HER2 Breast Cancer. Clinical Breast Cancer. PMID 30846407 DOI: 10.1016/J.Clbc.2019.02.001 |
0.314 |
|
| 2019 |
Akce M, Jiang R, Alese OB, Shaib WL, Wu C, Behera M, El-Rayes BF. Gastric squamous cell carcinoma and gastric adenosquamous carcinoma, clinical features and outcomes of rare clinical entities: a National Cancer Database (NCDB) analysis. Journal of Gastrointestinal Oncology. 10: 85-94. PMID 30788163 DOI: 10.21037/Jgo.2018.10.06 |
0.306 |
|
| 2019 |
El Osta B, Behera M, Kim S, Berry LD, Sica G, Pillai RN, Owonikoko TK, Kris MG, Johnson BE, Kwiatkowski DJ, Sholl LM, Aisner DL, Bunn PA, Khuri FR, Ramalingam SS. Characteristics and outcomes of patients with metastatic KRAS mutant lung adenocarcinomas: The Lung Cancer Mutation Consortium experience. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30735816 DOI: 10.1016/J.Jtho.2019.01.020 |
0.422 |
|
| 2019 |
Alese OB, Zakka KM, Huo X, Jiang R, Shaib WL, Wu C, Akce M, Sullivan PS, Behera M, El-Rayes BF. Perioperative therapy in patients with metastatic colorectal cancer. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E18231 |
0.405 |
|
| 2019 |
Nazha B, Chen Z, Goyal S, Engelhart A, Carlisle JW, Beardslee T, Gill H, Odikadze L, Liu Y, Mishra MK, Behera M, Ramalingam SS, Owonikoko TK. Evaluating the role of race in outcome of advanced non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitor (ICI): Our institutional experience. Journal of Clinical Oncology. 37: 9042-9042. DOI: 10.1200/Jco.2019.37.15_Suppl.9042 |
0.465 |
|
| 2019 |
Press RH, Shafer SL, Jiang R, Buchwald ZS, Abugideiri M, Tian S, Morgan T, Behera M, Sengupta S, Voloschin AD, Olson JJ, Curran WJ, Eaton BR, Shu HG, Zhong J. The timing of chemoradiotherapy after surgical resection and its impact on overall survival in glioblastoma. Journal of Clinical Oncology. 37: 2051-2051. DOI: 10.1200/Jco.2019.37.15_Suppl.2051 |
0.319 |
|
| 2019 |
Obeng R, Behera M, Owonikoko T, Pillai R, Ahmed R, Ramalingam S, Sica G. P1.15 The Presence of Secondary Follicles in Early Stage Lung Adenocarcinoma Reflects Disease Burden Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.09.072 |
0.348 |
|
| 2019 |
Tian S, Switchenko J, Patel P, Shelton J, Kahn S, Pillai R, Steuer C, Owonikoko T, Behera M, Curran W, Higgins K. MA01.02 Lung Stereotactic Body Radiotherapy and Concurrent Immunotherapy: A Multi-Center Safety and Toxicity Analysis Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.494 |
0.367 |
|
| 2019 |
Gorgens S, Schreibmann E, Behera M, Steuer C, Pillai R, Owonikoko T, Shelton J, Ramalingam S, Curran W, Higgins K. P1.16-08 Integration of Durvalumab into the Treatment of Stage III Non-Small Cell Lung Cancer: Real-World Considerations Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.1234 |
0.44 |
|
| 2018 |
Alese OB, Jiang R, Shaib W, Wu C, Akce M, Behera M, El-Rayes BF. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study. The Oncologist. PMID 30482824 DOI: 10.1634/Theoncologist.2018-0382 |
0.317 |
|
| 2018 |
Ferris MJ, Jiang R, Behera M, Ramalingam SS, Curran WJ, Higgins KA. Radiation Therapy Is Associated With an Increased Incidence of Cardiac Events in Patients with Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 102: 383-390. PMID 30191870 DOI: 10.1016/J.Ijrobp.2018.05.066 |
0.429 |
|
| 2018 |
Li X, Zhang Y, Meisel J, Jiang R, Behera M, Peng L. Validation of the newly proposed American Joint Committee on Cancer (AJCC) breast cancer prognostic staging group and proposing a new staging system using the National Cancer Database. Breast Cancer Research and Treatment. PMID 29948405 DOI: 10.1007/S10549-018-4832-9 |
0.372 |
|
| 2018 |
Zhong J, Switchenko J, Behera M, Kooby D, Maithel SK, McDonald MW, Lin JY, Cassidy RJ, El-Rayes B, Landry J, Patel PR. Chemotherapy with or Without Definitive Radiation Therapy in Inoperable Pancreatic Cancer. Annals of Surgical Oncology. PMID 29327180 DOI: 10.1245/S10434-017-6322-4 |
0.401 |
|
| 2018 |
Alese OB, Jiang R, Shaib WL, Wu CS, Akce M, Behera M, El-Rayes BF. Epidemiology and treatment of high-grade gastrointestinal neuroendocrine tumors (HG-GI-NETs). Journal of Clinical Oncology. 36: 421-421. DOI: 10.1200/Jco.2018.36.4_Suppl.421 |
0.414 |
|
| 2018 |
Akce M, Jiang R, Wu C, Alese OB, Shaib WL, Behera M, El-Rayes BF. Incidence, treatment and survival outcomes of small bowel adenocarcinomas: A National Cancer Database (NCDB) analysis. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E16262 |
0.412 |
|
| 2018 |
Tian S, Jiang R, Madden NA, Ferris MJ, Buchwald Z, Xu KM, Cardona K, Maithel S, McDonald MW, Lin JY, Curran WJ, Behera M, El-Rayes BF, Patel PR. Survival outcomes in gastric and gastroesophageal junction adenocarcinoma treated with peri-operative chemotherapy with or without pre-operative radiotherapy. Journal of Clinical Oncology. 36: 4026-4026. DOI: 10.1200/Jco.2018.36.15_Suppl.4026 |
0.312 |
|
| 2018 |
Mohamed A, Jiang R, Philip PA, Diab M, Behera M, Wu C, El-Rayes BF, Akce M. Impact of adjuvant chemotherapy in higher risk stage II colon cancer with a deficient mismatch repair (dMMR)/ microsatellite instability-high (MSI-H) profile. Journal of Clinical Oncology. 36: 3604-3604. DOI: 10.1200/Jco.2018.36.15_Suppl.3604 |
0.358 |
|
| 2017 |
Pillai RN, Behera M, Owonikoko TK, Kamphorst AO, Pakkala S, Belani CP, Khuri FR, Ahmed R, Ramalingam SS. Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literature. Cancer. PMID 28960263 DOI: 10.1002/Cncr.31043 |
0.321 |
|
| 2017 |
Lin RJ, Behera M, Diefenbach CS, Flowers CR. The Role of Anthracycline and Comprehensive Geriatric Assessment for Elderly Patients with Diffuse Large B-cell Lymphoma. Blood. PMID 28814386 DOI: 10.1182/Blood-2017-05-736975 |
0.33 |
|
| 2017 |
Pillai RN, Behera M, Berry LD, Rossi MR, Kris MG, Johnson BE, Bunn PA, Ramalingam SS, Khuri FR. HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium. Cancer. PMID 28743157 DOI: 10.1002/Cncr.30869 |
0.387 |
|
| 2017 |
Cassidy RJ, Zhang X, Patel PR, Shelton JW, Escott CE, Sica GL, Rossi MR, Hill CE, Steuer CE, Pillai RN, Ramalingam SS, Owonikoko TK, Behera M, Force SD, Fernandez FG, et al. Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy. Cancer. PMID 28608966 DOI: 10.1002/Cncr.30794 |
0.392 |
|
| 2017 |
Ahmed HZ, Liu Y, O'Connell K, Ahmed MZ, Cassidy RJ, Gillespie TW, Patel P, Pillai RN, Behera M, Steuer CE, Owonikoko TK, Ramalingam SS, Curran WJ, Higgins KA. Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis. Clinical Lung Cancer. PMID 28601387 DOI: 10.1016/J.Cllc.2017.04.009 |
0.475 |
|
| 2017 |
Kamphorst AO, Pillai RN, Yang S, Nasti TH, Akondy RS, Wieland A, Sica GL, Yu K, Koenig L, Patel NT, Behera M, Wu H, McCausland M, Chen Z, Zhang C, et al. Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients. Proceedings of the National Academy of Sciences of the United States of America. PMID 28446615 DOI: 10.1073/Pnas.1705327114 |
0.324 |
|
| 2017 |
Gilbert-Ross M, Konen J, Koo J, Shupe J, Robinson BS, Wiles WG, Huang C, Martin WD, Behera M, Smith GH, Hill CE, Rossi MR, Sica GL, Rupji M, Chen Z, et al. Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma. Jci Insight. 2: e90487. PMID 28289710 DOI: 10.1172/Jci.Insight.90487 |
0.364 |
|
| 2017 |
Higgins KA, O'Connell K, Liu Y, Gillespie TW, McDonald MW, Pillai RN, Patel KR, Patel PR, Robinson CG, Simone CB, Owonikoko TK, Belani CP, Khuri FR, Curran WJ, Ramalingam SS, ... Behera M, et al. National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 97: 128-137. PMID 27979443 DOI: 10.1016/J.Ijrobp.2016.10.001 |
0.468 |
|
| 2017 |
Alese OB, Jiang R, Shaib WL, Wu CS, Behera M, El-Rayes BF. Treatment, outcomes, and impact of racial disparities on young adults with pancreatic cancer. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E18069 |
0.346 |
|
| 2017 |
El Osta BE, Behera M, Kim S, Berry LD, Sica G, Pillai RN, Owonikoko TK, Kris MG, Johnson BE, Kwiatkowski DJ, Bunn PA, Khuri FR, Ramalingam SS. Characteristics and outcomes of patients (pts) with metastatic KRAS mutant lung adenocarcinomas: Lung Cancer Mutation Consortium (LCMC) database. Journal of Clinical Oncology. 35: 9021-9021. DOI: 10.1200/Jco.2017.35.15_Suppl.9021 |
0.352 |
|
| 2017 |
Higgins KA, Zhang X, Jiang R, Pillai RN, Owonikoko TK, Steuer CE, Saba NF, Pakkala S, Patel PR, Belani CP, Khuri FR, Curran WJ, Ramalingam SS, Behera M. Survival outcomes in extensive stage small cell lung cancer patients treated with thoracic radiation. Journal of Clinical Oncology. 35: 8565-8565. DOI: 10.1200/Jco.2017.35.15_Suppl.8565 |
0.328 |
|
| 2017 |
Behera M, Zhang X, Jiang R, Pillai RN, Patel PR, Pakkala S, Steuer CE, Saba NF, Owonikoko TK, Belani C, Khuri FR, Curran WJ, Ramalingam SS, Higgins KA. Optimal thoracic radiation dose in limited stage small cell lung cancer. Journal of Clinical Oncology. 35: 8562-8562. DOI: 10.1200/Jco.2017.35.15_Suppl.8562 |
0.388 |
|
| 2017 |
Alese OB, Jiang R, Shaib WL, Wu CS, Behera M, El-Rayes BF. Racial disparities in treatment and outcomes of colorectal cancer in young adults. Journal of Clinical Oncology. 35: 6559-6559. DOI: 10.1200/Jco.2017.35.15_Suppl.6559 |
0.332 |
|
| 2017 |
Zhong J, Switchenko JM, Behera M, Kooby DA, McDonald MW, El-Rayes BF, Landry JC, Patel PR. Chemotherapy with or without definitive radiation therapy in locally advanced pancreatic cancer. Journal of Clinical Oncology. 35: 4103-4103. DOI: 10.1200/Jco.2017.35.15_Suppl.4103 |
0.404 |
|
| 2017 |
Goldstein JS, Switchenko JM, Behera M, Flowers C, Koff JL. Insurance Status Impacts Survival in Burkitt Lymphoma Blood. 130: 916-916. DOI: 10.1182/Blood.V130.Suppl_1.916.916 |
0.381 |
|
| 2017 |
Ferris M, Jiang R, Ward K, Ramalingam S, Behera M, Higgins K. OA 01.06 Radiation Therapy is Associated with an Increased Incidence of Cardiac Events in Small Cell Lung Cancer Patients Journal of Thoracic Oncology. 12: S1745. DOI: 10.1016/J.Jtho.2017.09.326 |
0.413 |
|
| 2017 |
Behera M, Jiang R, Higgins K, Pillai R, Owonikoko T, Belani C, Khuri F, Ward K, Curran W, Ramalingam S. P3.13-027 Utilization of PET Scan in Advanced Stage Non-Small Cell Lung Cancer in the United States Journal of Thoracic Oncology. 12: S2325-S2326. DOI: 10.1016/J.Jtho.2017.09.1762 |
0.413 |
|
| 2017 |
Kim S, Ragin C, Chen Z, Behera M, Pillai R, Steuer C, Belani C, Khuri F, Ramalingam S, Owonikoko T. P1.07-014 Impact of Chemotherapy for Small Cell Lung Cancer in the Third Line and beyond, a SEER-MEDICARE Analysis Journal of Thoracic Oncology. 12: S703-S704. DOI: 10.1016/J.Jtho.2016.11.925 |
0.447 |
|
| 2017 |
Behera M, Gillespie T, Liu Y, Jia Y, Higgins K, Steuer C, Saba N, Shin D, Pakkala S, Pillai R, Owonikoko T, Curran W, Belani C, Khuri F, Ramalingam S. P1.01-035 Trends, Patterns of Treatment and Outcomes in Non-Small Cell Lung Cancer (NSCLC) as a Second Primary: A National Cancer Data Base (NCDB) Analysis Journal of Thoracic Oncology. 12: S470. DOI: 10.1016/J.Jtho.2016.11.559 |
0.477 |
|
| 2017 |
Pillai R, Behera M, Owonikoko T, Kamphorst A, Pakkala S, Belani C, Khuri F, Ahmed R, Ramalingam S. OA03.06 Evaluation of Toxicity Profile of PD-1 versus PD-L1 Inhibitors in Non-Small Cell Lung Cancer (NSCLC) Journal of Thoracic Oncology. 12: S253-S254. DOI: 10.1016/J.Jtho.2016.11.242 |
0.356 |
|
| 2017 |
Ahmed H, Liu Y, O'Connell K, Gillespie T, Ahmed M, Patel P, Pillai R, Behera M, Steuer C, Owonikoko T, Ramalingam S, Curran W, Higgins K. P2.02-015 Guideline Concordant Care is Associated with Better Survival for Patients with Stage III Non-Small Cell Lung Cancer: Topic: Clinical Outcome Journal of Thoracic Oncology. 12. DOI: 10.1016/J.Jtho.2016.11.1162 |
0.473 |
|
| 2017 |
Cassidy R, Zhang X, Patel P, Shelton J, Escott C, Sica G, Rossi M, Hill C, Steuer C, Pillai R, Ramalingam S, Owonikoko T, Behera M, Force S, Fernandez F, et al. Next Generation Sequencing and Clinical Outcomes of Lung Adenocarcinomas Treated With Stereotactic Body Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 99: S241. DOI: 10.1016/J.Ijrobp.2017.06.588 |
0.359 |
|
| 2017 |
Madden N, Higgins K, Zaenger D, Cardona K, Landry J, Behera M, Liu Y, Patel P. Optimal Neoadjuvant Radiotherapy Dose for Esophageal Cancer: An NCDB Analysis of 41.4 Gy Versus 50.4 Gy International Journal of Radiation Oncology*Biology*Physics. 99: E169-E170. DOI: 10.1016/J.Ijrobp.2017.06.1007 |
0.337 |
|
| 2016 |
Steuer CE, Behera M, Liu Y, Fu C, Gillespie TW, Saba NF, Shin DM, Pillai RN, Pakkala S, Owonikoko TK, Khuri FR, Ramalingam SS. Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base. Clinical Lung Cancer. PMID 28043773 DOI: 10.1200/Jco.2015.33.15_Suppl.7537 |
0.455 |
|
| 2016 |
Steuer CE, Behera M, Ernani V, Higgins KA, Saba NF, Shin DM, Pakkala S, Pillai RN, Owonikoko TK, Curran WJ, Belani CP, Khuri FR, Ramalingam SS. Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review. Jama Oncology. PMID 27978552 DOI: 10.1001/Jamaoncol.2016.4280 |
0.485 |
|
| 2016 |
Cohen JB, Behera M, Thompson CA, Flowers CR. Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma. Blood. PMID 27956385 DOI: 10.1182/Blood-2016-08-685073 |
0.308 |
|
| 2016 |
Higgins KA, Jia Y, Liu Y, Force S, Fernandez F, Ramalingam S, Behera M, Owonikoko TK, Pillai RN, Simone CB, Robinson CG, Curran WJ, Gillespie TW, Patel PR. Lung Stereotactic Body Radiation Therapy (SBRT) Versus Pneumonectomy in Patients With Non-Small Cell Lung Cancer (NSCLC) Ages 70 or Older. International Journal of Radiation Oncology, Biology, Physics. 96: E468. PMID 27674770 DOI: 10.1016/J.Ijrobp.2016.06.1806 |
0.446 |
|
| 2016 |
Higgins KA, O'Connell K, Liu Y, Patel PR, Pillai RN, Owonikoko TK, Simone CB, Robinson CG, McDonald MW, Gillespie TW, Ramalingam S, Curran WJ, Behera M. Better Overall Survival with Advanced Radiation Treatment Modalities in Stage II and III Non-Small Cell Lung Cancer (NSCLC): A National Cancer Data Base Analysis. International Journal of Radiation Oncology, Biology, Physics. 96: E438-E439. PMID 27674691 DOI: 10.1016/J.Ijrobp.2016.06.1731 |
0.482 |
|
| 2016 |
Behera M, Owonikoko TK, Gal AA, Steuer CE, Kim S, Pillai RN, Khuri FR, Ramalingam SS, Sica GL. Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma. Clinical Lung Cancer. PMID 27137345 DOI: 10.1016/J.Cllc.2016.03.009 |
0.43 |
|
| 2016 |
Pillai RN, Kamphorst AO, Owonikoko TK, Behera M, Pakkala S, Khuri FR, Ahmed R, Ramalingam SS. Liver metastases and sensitivity to checkpoint inhibition in patients with non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E20665 |
0.365 |
|
| 2016 |
Patel N, Behera M, Pillai RN, Owonikoko TK, Pakkala S, Belani CP, Khuri FR, Ramalingam SS. Role of anti-EGFR monoclonal antibody in EGFR FISH positive NSCLC patients: A meta-analysis of phase III randomized controlled trials. Journal of Clinical Oncology. 34: e20650-e20650. DOI: 10.1200/Jco.2016.34.15_Suppl.E20650 |
0.305 |
|
| 2016 |
Behera M, Gillespie TW, Liu Y, Jia Y, Higgins KA, Steuer CE, Saba NF, Shin DM, Pakkala S, Pillai RN, Owonikoko TK, Curran WJ, Belani CP, Khuri FR, Ramalingam SS. Non-small cell lung cancer (NSCLC) as a second primary: Analysis of the National Cancer Data Base (NCDB). Journal of Clinical Oncology. 34: e20022-e20022. DOI: 10.1200/Jco.2016.34.15_Suppl.E20022 |
0.464 |
|
| 2016 |
Behera M, OConnell KA, Liu Y, Gillespie TW, Pillai RN, Patel P, Simone CB, Robinson CG, Owonikoko TK, Belani CP, Khuri FR, Curran WJ, Ramalingam SS, Higgins KA. National Cancer Data Base analysis of proton versus photon radiotherapy in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 34: 8501-8501. DOI: 10.1200/Jco.2016.34.15_Suppl.8501 |
0.451 |
|
| 2016 |
Gilbert-Ross M, Konen J, Koo J, Shupe J, Sica GL, Chen Z, Robinson BS, Behera M, Rossi MR, Smith GH, Hill CE, Ramalingam SM, Fu H, Khuri FR, Zhou W, et al. Abstract LB-348: Developing a personalized anti-metastatic therapy to treat KRAS, LKB1-mutant lung adenocarcinoma Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-348 |
0.397 |
|
| 2015 |
Steuer CE, Behera M, Berry L, Kim S, Rossi M, Sica G, Owonikoko TK, Johnson BE, Kris MG, Bunn PA, Khuri FR, Garon EB, Ramalingam SS. Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium. Cancer. PMID 26695526 DOI: 10.1002/Cncr.29812 |
0.432 |
|
| 2015 |
Behera M, Ragin C, Kim S, Pillai RN, Chen Z, Steuer CE, Saba NF, Belani CP, Khuri FR, Ramalingam SS, Owonikoko TK. Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005. Cancer. PMID 26441041 DOI: 10.1002/Cncr.29674 |
0.472 |
|
| 2015 |
Behera M, Pillai RN, Owonikoko TK, Kim S, Steuer C, Chen Z, Saba NF, Belani CP, Khuri FR, Ramalingam SS. Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic Review. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 1142-7. PMID 26200267 DOI: 10.1097/Jto.0000000000000572 |
0.46 |
|
| 2015 |
Steuer CE, Behera M, Kim S, Patel N, Chen Z, Pillai R, Saba NF, Shin DM, Owonikoko TK, Khuri FR, Ramalingam SS. Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis. Lung Cancer (Amsterdam, Netherlands). 88: 80-4. PMID 25726042 DOI: 10.1016/J.Lungcan.2015.01.022 |
0.442 |
|
| 2015 |
Owonikoko TK, Ramalingam SS, Miller DL, Force SD, Sica GL, Mendel J, Chen Z, Rogatko A, Tighiouart M, Harvey RD, Kim S, Saba NF, Pickens A, Behera M, Fu RW, et al. A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1859-68. PMID 25673697 DOI: 10.1158/1078-0432.Ccr-14-1998 |
0.476 |
|
| 2015 |
Steuer CE, Behera M, Kim S, Chen Z, Saba NF, Pillai RN, Owonikoko TK, Khuri FR, Ramalingam SS. Atypical carcinoid tumor of the lung: a surveillance, epidemiology, and end results database analysis. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 479-85. PMID 25371080 DOI: 10.1097/Jto.0000000000000419 |
0.386 |
|
| 2015 |
Geiger C, Chen Z, Zhang C, Behera M, Steuer CE, Pillai RN, Ramalingam SS. Investigating the correlation between disease burden and symptoms in patients with advanced stage lung cancer. Journal of Clinical Oncology. 33: e19057-e19057. DOI: 10.1200/Jco.2015.33.15_Suppl.E19057 |
0.439 |
|
| 2015 |
Behera M, Pillai RN, Owonikoko TK, Pakkala S, Steuer CE, Saba NF, Shin DM, Belani CP, Khuri FR, Ramalingam SS. Pemetrexed versus taxane-containing platinum doublet therapy for advanced non-squamous non-small cell lung cancer (NSCLC): A systematic analysis. Journal of Clinical Oncology. 33: e19046-e19046. DOI: 10.1200/Jco.2015.33.15_Suppl.E19046 |
0.463 |
|
| 2015 |
Owonikoko TK, Kowalski J, Kim S, Dwivedi B, Chen Z, Behera M, Mayfield W, Hermann RC, Chen L, Khuri FR, Ramalingam SS, Sica G. PD-L1, PD-1, and CTLA-4 as prognostic biomarkers in resected non-small cell lung cancer. Journal of Clinical Oncology. 33: 7551-7551. DOI: 10.1200/Jco.2015.33.15_Suppl.7551 |
0.401 |
|
| 2015 |
Owonikoko TK, Nelson M, Park SY, Kim S, Steuer CE, Behera M, Chen Z, Han E, Kumar M, Ernani V, Saba NF, Khuri FR, Ramalingam SS, Rossi MR. Aneuploidy of anaplastic lymphoma kinase (ALK) gene and association with non squamous lung cancer patient characteristics and outcomes. Journal of Clinical Oncology. 33: 7549-7549. DOI: 10.1200/Jco.2015.33.15_Suppl.7549 |
0.382 |
|
| 2015 |
Steuer CE, Behera M, Higgins KA, Saba NF, Shin DM, Pakkala S, Pillai RN, Owonikoko TK, Curran WJ, Belani CP, Khuri FR, Ramalingam SS. Comparison of concurrent use of carboplatin-Paclitaxel versus cisplatin-etoposide with thoracic radiation for stage III NSCLC patients: A systematic review. Journal of Clinical Oncology. 33: 7536-7536. DOI: 10.1200/Jco.2015.33.15_Suppl.7536 |
0.454 |
|
| 2015 |
Behera M, Steuer CE, Fernandez F, Liu Y, Fu C, Gillespie TW, Higgins KA, Saba NF, Pillai RN, Force S, Pakkala S, Shin DM, Owonikoko TK, Belani CP, Curran WJ, et al. Trimodality therapy in the treatment of stage IIIA non-small cell lung cancer (NSCLC): Analysis of the National Cancer Database. Journal of Clinical Oncology. 33: 7514-7514. DOI: 10.1200/Jco.2015.33.15_Suppl.7514 |
0.467 |
|
| 2015 |
MOHAMED A, Schrapp K, Owonikoko TK, Steuer CE, Chen Z, Pakkala S, Pillai RN, Wadsworth JT, Higgins KA, Ramalingam SS, Beitler JJ, Shin DM, Khuri FR, Behera M, Saba NF. Concurrent chemoradiation using weekly versus tri-weekly cisplatin in locally advanced squamous cell carcinoma of the head and neck (SCCHN): A comparative analysis. Journal of Clinical Oncology. 33: 6055-6055. DOI: 10.1200/Jco.2015.33.15_Suppl.6055 |
0.313 |
|
| 2015 |
Nooka AK, Kaufman JL, Behera M, Gleason C, Collins H, Gupta VA, Boise LH, Lonial S. Efficacy and Safety of Triplet Versus Doublet Salvage Therapies Among Patients with Multiple Myeloma (MM) Experiencing Early Relapse: Meta-Analysis of Phase III Randomized Controlled Trials (RCTs) Blood. 126: 5344-5344. DOI: 10.1182/Blood.V126.23.5344.5344 |
0.323 |
|
| 2014 |
Behera M, Owonikoko TK, Kim S, Chen Z, Higgins K, Ramalingam SS, Shin DM, Khuri FR, Beitler JJ, Saba NF. Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic review. Oral Oncology. 50: 888-94. PMID 25060589 DOI: 10.1016/J.Oraloncology.2014.06.014 |
0.326 |
|
| 2014 |
Brodie SA, Li G, El-Kommos A, Kang H, Ramalingam SS, Behera M, Gandhi K, Kowalski J, Sica GL, Khuri FR, Vertino PM, Brandes JC. Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer. Cancer Prevention Research (Philadelphia, Pa.). 7: 351-61. PMID 24441677 DOI: 10.1158/1940-6207.Capr-13-0254 |
0.325 |
|
| 2014 |
Steuer CE, Behera M, Kim S, Patel N, Chen Z, Pillai RN, Saba NF, Shin DM, Owonikoko TK, Khuri FR, Ramalingam SS. Predictors and outcomes of venous thromboembolism (VTE) in hospitalized lung cancer patients: A nationwide inpatient sample (NIS) database analysis. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E17632 |
0.435 |
|
| 2014 |
Behera M, Steuer CE, Kim S, Pillai RN, Chen Z, Owonikoko TK, Belani CP, Khuri FR, Ramalingam SS. Management approaches and outcomes of lung cancer patients hospitalized for malignant pleural effusions. Journal of Clinical Oncology. 32: 9646-9646. DOI: 10.1200/Jco.2014.32.15_Suppl.9646 |
0.422 |
|
| 2014 |
Pillai RN, Behera M, Berry LD, Rossi MR, Kris MG, Bunn PA, Khuri FR, Ramalingam SS. HER2 mutations in lung adenocarcinoma: A report from the Lung Cancer Mutation Consortium (LCMC). Journal of Clinical Oncology. 32: 8060-8060. DOI: 10.1200/Jco.2014.32.15_Suppl.8060 |
0.387 |
|
| 2014 |
Behera M, Ragin C, Kim S, Chen Z, Steuer CE, Saba NF, Pillai RN, Belani CP, Ramalingam SS, Khuri FR, Owonikoko TK. Trends in small cell lung cancer (SCLC) survival: Predictors and impact of systemic therapy. Journal of Clinical Oncology. 32: 7599-7599. DOI: 10.1200/Jco.2014.32.15_Suppl.7599 |
0.422 |
|
| 2014 |
Steuer CE, Behera M, Kim S, Chen Z, Pillai RN, Owonikoko TK, Khuri FR, Ramalingam SS. Clinical characteristics and outcomes of atypical carcinoid (AC) tumor of the lung: A Surveillance, Epidemiology, and End Results database analysis. Journal of Clinical Oncology. 32: 7554-7554. DOI: 10.1200/Jco.2014.32.15_Suppl.7554 |
0.414 |
|
| 2014 |
Kazi H, Behera M, Steuer C, Pillai R, Owonikoko T, Khuri F, Ramalingam S. Evaluation of Hospitalization Trends in Lung Cancer Patients With Hyponatremia International Journal of Radiation Oncology*Biology*Physics. 90: S62. DOI: 10.1016/J.Ijrobp.2014.08.280 |
0.418 |
|
| 2014 |
Steuer C, Behera M, Rossi M, Fisher K, Sica G, Gal A, Pakkala S, Pillai R, Owonikoko T, Khuri F, Ramalingam S. Investigating the Molecular Profile of Lung Adenocarcinoma: A Single-Institution Analysis International Journal of Radiation Oncology*Biology*Physics. 90: S50-S51. DOI: 10.1016/J.Ijrobp.2014.08.246 |
0.367 |
|
| 2014 |
Behera M, Steuer C, Gal A, Owonikoko T, Khuri F, Ramalingam S, Sica G. Lung Adenocarcinoma Staging Based on 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ (AIS) and Minimally Invasive Adenocarcinoma (MIA) International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.08.143 |
0.384 |
|
| 2014 |
Hall W, Steuer C, Nickleach D, Behera M, Owonikoko T, Higgins K, Khuri F, Curran W, Ramalingam S. A Comparison of Palliative Inpatient Management Strategies for Cancer-Related Superior Vena Cava Obstruction International Journal of Radiation Oncology*Biology*Physics. 90: S68-S69. DOI: 10.1016/J.Ijrobp.2014.05.465 |
0.324 |
|
| 2013 |
Nooka AK, Kaufman JL, Behera M, Langston A, Waller EK, Flowers CR, Gleason C, Boise LH, Lonial S. Bortezomib-containing induction regimens in transplant-eligible myeloma patients: a meta-analysis of phase 3 randomized clinical trials. Cancer. 119: 4119-28. PMID 24005889 DOI: 10.1002/Cncr.28325 |
0.337 |
|
| 2013 |
Owonikoko TK, Ragin C, Chen Z, Kim S, Behera M, Brandes JC, Saba NF, Pentz R, Ramalingam SS, Khuri FR. Real-world effectiveness of systemic agents approved for advanced non-small cell lung cancer: a SEER-Medicare analysis. The Oncologist. 18: 600-10. PMID 23635558 DOI: 10.1634/Theoncologist.2012-0480 |
0.481 |
|
| 2013 |
Ramalingam SS, Owonikoko TK, Behera M, Subramanian J, Saba NF, Kono SA, Gal AA, Sica G, Harvey RD, Chen Z, Klass CM, Shin DM, Fu H, Sun SY, Govindan R, et al. Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 369-72. PMID 23407561 DOI: 10.1097/Jto.0B013E318282709C |
0.451 |
|
| 2013 |
Behera M, Heine JJ, Sica GL, Fowler EE, Tran H, Fu RW, Gal AA, Hermann R, Mayfield W, Khuri FR, Owonikoko TK, Ramalingam SS. Survival analysis of patients with stage I non-small-cell lung cancer using clinical and DNA repair pathway expression variables. Clinical Lung Cancer. 14: 128-38. PMID 22921042 DOI: 10.1016/J.Cllc.2012.06.001 |
0.699 |
|
| 2013 |
Behera M, Pillai RN, Owonikoko TK, Kim S, Chen Z, Saba NF, Belani CP, Khuri FR, Ramalingam SS. Bevacizumab in combination with taxane versus non-taxane-containing regimens for advanced/metastatic nonsquamous non-small-cell lung cancer (NSCLC): A systematic review. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E19094 |
0.396 |
|
| 2013 |
Owonikoko TK, Miller DL, Force S, Sica G, Kono S, Behera M, Mendel J, Chen Z, Pickens A, Fu RW, Auffermann WF, Rogerio J, Torres WE, Fu H, Hohneker J, et al. Abstract LB-194: Window of opportunity preoperative interrogation of mTOR pathway in patients with resectable non-small cell lung cancer (NSCLC). Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-194 |
0.41 |
|
| 2012 |
Owonikoko TK, Behera M, Chen Z, Bhimani C, Curran WJ, Khuri FR, Ramalingam SS. A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 866-72. PMID 22722788 DOI: 10.1097/Jto.0B013E31824C7F4B |
0.448 |
|
| 2012 |
Behera M, Owonikoko TK, Chen Z, Kono SA, Khuri FR, Belani CP, Ramalingam SS. Single agent maintenance therapy for advanced stage non-small cell lung cancer: a meta-analysis. Lung Cancer (Amsterdam, Netherlands). 77: 331-8. PMID 22546678 DOI: 10.1200/Jco.2011.29.15_Suppl.7553 |
0.483 |
|
| 2012 |
Behera M, Beitler JJ, Bhimani C, Higgins K, Chen Z, Kim S, Deng X, Curran WJ, Khuri FR, Ramalingam SS, Owonikoko TK. A systematic analysis of high-dose radiation in the treatment of surgically unresectable, locally advanced non-small cell lung cancer. Journal of Clinical Oncology. 30: 7059-7059. DOI: 10.1200/Jco.2012.30.15_Suppl.7059 |
0.384 |
|
| 2011 |
Khuri FR, Owonikoko TK, Subramanian J, Sica G, Behera M, Saba NF, Chen Z, Tighiouart M, Shin DM, Sun S, Fu R, Gal A, Govindan R, Ramalingam SS. Everolimus, an mTOR inhibitor, in combination with docetaxel for second- or third-line therapy of advanced-stage non-small cell lung cancer: A phase II study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e13601. PMID 28023520 DOI: 10.1200/Jco.2011.29.15_Suppl.E13601 |
0.455 |
|
| 2011 |
Owonikoko TK, Behera M, Tran HN, Chen Z, Chowdry RP, Saba NF, Ramalingam SS, Khuri FR. Systematic comparative analysis of efficacy of EGFR tyrosine kinase inhibitors (TKIs) in the frontline versus salvage therapy of NSCLC. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 7602. PMID 28023322 DOI: 10.1200/Jco.2011.29.15_Suppl.7602 |
0.363 |
|
| 2011 |
Behera M, Owonikoko TK, Chen Z, Kono SA, Khuri FR, Belani CP, Ramalingam SS. Single-agent maintenance therapy for advanced-stage non-small cell lung cancer: A meta-analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 7553. PMID 28023180 DOI: 10.1200/jco.2011.29.15_suppl.7553 |
0.373 |
|
| 2011 |
Behera M, Fowler EE, Owonikoko TK, Land WH, Mayfield W, Chen Z, Khuri FR, Ramalingam SS, Heine JJ. Statistical learning methods as a preprocessing step for survival analysis: evaluation of concept using lung cancer data. Biomedical Engineering Online. 10: 97. PMID 22067671 DOI: 10.1186/1475-925X-10-97 |
0.64 |
|
| 2011 |
Nooka AK, Behera M, Boise LH, Watson M, Kaufman JL, Lonial S. Thalidomide As Maintenance Therapy in Multiple Myeloma (MM) Improves Progression Free Survival (PFS) and Overall Survival (OS): A Meta-Analysis Blood. 118: 1855-1855. DOI: 10.1182/Blood.V118.21.1855.1855 |
0.336 |
|
| 2010 |
Owonikoko TK, Ramalingam SS, Behera M, Brandes JC, Saba NF, Bhimani C, Harichand-Herdt S, Shin DM, Khuri FR, Ragin C. Survival impact of newly approved therapeutic agents in patients with advanced non-small cell lung cancer (NSCLC): A SEER-Medicare database analysis. Journal of Clinical Oncology. 28: 7633-7633. DOI: 10.1200/Jco.2010.28.15_Suppl.7633 |
0.45 |
|
| 2006 |
Heine JJ, Behera M. Effective x-ray attenuation measurements with full field digital mammography. Medical Physics. 33: 4350-66. PMID 17153414 DOI: 10.1118/1.2356648 |
0.558 |
|
| 2006 |
Heine JJ, Behera M. Aspects of signal-dependent noise characterization. Journal of the Optical Society of America. a, Optics, Image Science, and Vision. 23: 806-15. PMID 16604760 DOI: 10.1364/Josaa.23.000806 |
0.518 |
|
| Show low-probability matches. |